376 related articles for article (PubMed ID: 32664884)
1. Roles of contrast-enhanced ultrasonography in identifying volume change of benign thyroid nodule and optical time of secondary radiofrequency ablation.
Jiao Z; Luo Y; Song Q; Yan L; Zhu Y; Xie F
BMC Med Imaging; 2020 Jul; 20(1):79. PubMed ID: 32664884
[TBL] [Abstract][Full Text] [Related]
2. A Novel Strategy for Single-Session Ultrasound-Guided Radiofrequency Ablation of Large Benign Thyroid Nodules: A Pilot Cohort Study.
Yao Z; Wu T; Zheng B; Tan L; Lian Y; Liu B; Ren J
Front Endocrinol (Lausanne); 2020; 11():560508. PubMed ID: 33117279
[No Abstract] [Full Text] [Related]
3. Five-Year Results of Radiofrequency and Laser Ablation of Benign Thyroid Nodules: A Multicenter Study from the Italian Minimally Invasive Treatments of the Thyroid Group.
Bernardi S; Giudici F; Cesareo R; Antonelli G; Cavallaro M; Deandrea M; Giusti M; Mormile A; Negro R; Palermo A; Papini E; Pasqualini V; Raggiunti B; Rossi D; Sconfienza LM; Solbiati L; Spiezia S; Tina D; Vera L; Stacul F; Mauri G
Thyroid; 2020 Dec; 30(12):1759-1770. PubMed ID: 32578498
[No Abstract] [Full Text] [Related]
4. Safety and Efficacy of Ultrasound-Guided Radiofrequency Ablation for Benign Nonfunctional Thyroid Nodules in Children: A Retrospective Study of 62 Patients with Over Four Years of Follow-Up.
Li L; Qiu X
Thyroid; 2022 May; 32(5):525-535. PubMed ID: 34915754
[No Abstract] [Full Text] [Related]
5. Long-Term Results of Ultrasound-Guided Radiofrequency Ablation of Benign Thyroid Nodules: State of the Art and Future Perspectives-A Systematic Review.
Monpeyssen H; Alamri A; Ben Hamou A
Front Endocrinol (Lausanne); 2021; 12():622996. PubMed ID: 34122328
[TBL] [Abstract][Full Text] [Related]
6. Factors associated with initial incomplete ablation for benign thyroid nodules after radiofrequency ablation: First results of CEUS evaluation.
Zhao CK; Xu HX; Lu F; Sun LP; He YP; Guo LH; Li XL; Bo XW; Yue WW
Clin Hemorheol Microcirc; 2017; 65(4):393-405. PubMed ID: 27983547
[TBL] [Abstract][Full Text] [Related]
7. A Nomogram to Predict Regrowth After Ultrasound-Guided Radiofrequency Ablation for Benign Thyroid Nodules.
Yan L; Zhang M; Li X; Li Y; Luo Y
Front Endocrinol (Lausanne); 2021; 12():774228. PubMed ID: 35250847
[TBL] [Abstract][Full Text] [Related]
8. Residual vital ratio: predicting regrowth after radiofrequency ablation for benign thyroid nodules.
Yan L; Luo Y; Xie F; Zhang M; Xiao J
Int J Hyperthermia; 2020; 37(1):1139-1148. PubMed ID: 32996790
[TBL] [Abstract][Full Text] [Related]
9. Vital volume increase versus clinical evaluation as the indication of additional radiofrequency ablation for benign thyroid nodule: a single center retrospective study.
Yan L; Luo Y; Zhang M; Xiao J
Int J Hyperthermia; 2020; 37(1):777-785. PubMed ID: 32619366
[No Abstract] [Full Text] [Related]
10. Solid benign thyroid nodules (>10 ml): a retrospective study on the efficacy and safety of sonographically guided ethanol ablation combined with radiofrequency ablation.
Zhu Y; Zhang M; Jin Z; Tian X; Zhang Y; Xie F; Song Q; Yan L; Jiang B; Tang J; Luo Y
Int J Hyperthermia; 2020; 37(1):157-167. PubMed ID: 32024398
[No Abstract] [Full Text] [Related]
11. Comparison of ultrasound-guided microwave ablation, laser ablation, and radiofrequency ablation for the treatment of elderly patients with benign thyroid nodules: A meta-analysis.
Qian Y; Li Z; Fan C; Huang Y
Exp Gerontol; 2024 Jun; 191():112425. PubMed ID: 38604254
[TBL] [Abstract][Full Text] [Related]
12. Successful radiofrequency ablation strategies for benign thyroid nodules.
Lee GM; You JY; Kim HY; Chai YJ; Kim HK; Dionigi G; Tufano RP
Endocrine; 2019 May; 64(2):316-321. PubMed ID: 30569260
[TBL] [Abstract][Full Text] [Related]
13. Non-enhanced ultrasound is not a satisfactory modality for measuring necrotic ablated volume after radiofrequency ablation of benign thyroid nodules: a comparison with contrast-enhanced ultrasound.
Yan L; Luo Y; Xiao J; Lin L
Eur Radiol; 2021 May; 31(5):3226-3236. PubMed ID: 33128600
[TBL] [Abstract][Full Text] [Related]
14. Delayed Cancer Diagnosis in Thyroid Nodules Initially Treated as Benign With Radiofrequency Ablation: Ultrasound Characteristics and Predictors for Cancer.
Kim MK; Shin JH; Hahn SY; Kim H
Korean J Radiol; 2023 Sep; 24(9):903-911. PubMed ID: 37634644
[TBL] [Abstract][Full Text] [Related]
15. Residual, regrowth, and new growth of radiofrequency ablation for benign thyroid nodules of different volumes: two-year follow-up results.
Chen MH; Lin WC; Luo SD; Chiang PL; Chen YS; Chen WC; Lin AN; Wang CK; Baek JH; Chen HL
Int J Hyperthermia; 2022; 39(1):1172-1178. PubMed ID: 36096486
[TBL] [Abstract][Full Text] [Related]
16. Sequential treatment by polidocanol and radiofrequency ablation of large benign partially cystic thyroid nodules with solid components: Efficacy and safety.
Lin Y; Li P; Shi YP; Tang XY; Ding M; He Y; Zhai B
Diagn Interv Imaging; 2020 Jun; 101(6):365-372. PubMed ID: 31889636
[TBL] [Abstract][Full Text] [Related]
17. Initial Ablation Ratio Predicts Volume Reduction and Retreatment After 5 Years From Radiofrequency Ablation of Benign Thyroid Nodules.
Bernardi S; Cavallaro M; Colombin G; Giudici F; Zuolo G; Zdjelar A; Dobrinja C; De Manzini N; Zanconati F; Cova MA; Stacul F; Fabris B
Front Endocrinol (Lausanne); 2020; 11():582550. PubMed ID: 33597921
[TBL] [Abstract][Full Text] [Related]
18. A New Perspective for Predicting the Therapeutic Success of RFA in Solid BTNs: Quantitative Initial RFA Ratio by Contrast-Enhanced Ultrasound.
Zhu Y; Jiao Z; Zhu L; Xie F; Song Q; Yan L; Luo Y; Zhang M
Front Endocrinol (Lausanne); 2022; 13():904459. PubMed ID: 35774147
[TBL] [Abstract][Full Text] [Related]
19. Predictor Analysis in Radiofrequency Ablation of Benign Thyroid Nodules: A Single Center Experience.
Bisceglia A; Rossetto R; Garberoglio S; Franzin A; Cerato A; Maletta F; Papotti MG; Ghigo E; Pagano L; Maccario M; Garberoglio R
Front Endocrinol (Lausanne); 2021; 12():638880. PubMed ID: 34079521
[TBL] [Abstract][Full Text] [Related]
20. Laser Ablation Versus Radiofrequency Ablation for Benign Non-Functioning Thyroid Nodules: Six-Month Results of a Randomized, Parallel, Open-Label, Trial (LARA Trial).
Cesareo R; Pacella CM; Pasqualini V; Campagna G; Iozzino M; Gallo A; Lauria Pantano A; Cianni R; Pedone C; Pozzilli P; Taffon C; Crescenzi A; Manfrini S; Palermo A
Thyroid; 2020 Jun; 30(6):847-856. PubMed ID: 32056501
[No Abstract] [Full Text] [Related]
[Next] [New Search]
